Lineage Cell Therapeutics... (LCTX)
AMEX: LCTX
· Real-Time Price · USD
1.19
0.17 (16.67%)
At close: Aug 15, 2025, 3:59 PM
1.21
1.68%
After-hours: Aug 15, 2025, 06:47 PM EDT
Lineage Cell Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 10.91M | 9.56M | 9.5M | 8.72M | 6.19M | 8M | 8.95M | 8.77M | 10.52M | 11.85M | 14.7M | 13.75M | 12.95M | 8.84M | 3.9M | 3.1M | 1.24M | 900K |
Cost of Revenue | 228K | 272K | 509K | 786K | 917K | 1M | 846K | 517K | 583K | 671K | 728K | 830K | 1.58M | 1.49M | 1.43M | 1.34M | 453K | 403K |
Gross Profit | 7.92M | 9.29M | 8.99M | 7.93M | 5.27M | 7M | 8.1M | 8.26M | 9.94M | 11.18M | 13.97M | 12.92M | 11.37M | 7.35M | 2.47M | 1.77M | 789K | 497K |
Operating Income | -35.23M | -21.32M | -21.48M | -22.73M | -25.59M | -24.75M | -24.73M | -25.01M | -23.56M | -22.77M | -22.52M | -44.12M | -45.71M | -48.56M | -49.21M | -26.86M | -26.74M | -26.06M |
Interest Income | 1.27M | 1.73M | 1.72M | 1.73M | 1.76M | 1.68M | 1.63M | 2.05M | 2M | 1.67M | 1.26M | 439K | 55K | 4K | 5K | 4K | 256K | 636K |
Pretax Income | -40.85M | -16.16M | -18.58M | -20.05M | -24.2M | -23.63M | -23.28M | -24.93M | -23.35M | -24.93M | -25.81M | -47.46M | -50.73M | -48.91M | -43.27M | -14.28M | -13.38M | -14.94M |
Net Income | -40.91M | -16.21M | -18.61M | -20.11M | -24.19M | -23.66M | -21.52M | -23.34M | -22.34M | -27.08M | -30.97M | -53.37M | -55.08M | -49.9M | -43.02M | -11.99M | -11.93M | -13.67M |
Selling & General & Admin | 18.23M | 18.03M | 18.02M | 17.76M | 17.39M | 17.28M | 17.16M | 17.36M | 17.74M | 18.76M | 22.51M | 22.59M | 23.48M | 22.75M | 18.21M | 17.3M | 15.62M | 14.99M |
Research & Development | 12.81M | 12.58M | 12.45M | 12.9M | 13.47M | 14.48M | 15.67M | 15.9M | 15.75M | 15.18M | 13.99M | 34.66M | 33.88M | 33.51M | 33.91M | 11.74M | 12.5M | 12.37M |
Other Expenses | 14.88M | n/a | n/a | n/a | n/a | n/a | -16K | -16K | -16K | -16K | n/a | n/a | n/a | n/a | -1.68M | 1.02M | 1.38M | 2.55M |
Operating Expenses | 45.92M | 30.61M | 30.47M | 30.66M | 30.86M | 31.75M | 32.83M | 33.27M | 33.5M | 33.95M | 36.49M | 57.04M | 57.08M | 55.91M | 51.68M | 28.62M | 27.53M | 26.56M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3K | 4K | 7K | 7K | 4K | 3K | n/a |
Selling & Marketing Expenses | n/a | n/a | -153K | -296K | -296K | -296K | -143K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 23.6M | 30.88M | 30.98M | 31.45M | 31.78M | 32.76M | 33.68M | 33.78M | 34.08M | 34.62M | 37.22M | 57.87M | 58.66M | 57.4M | 53.11M | 29.96M | 27.98M | 26.96M |
Income Tax Expense | n/a | n/a | -16K | -16K | -16K | -16K | -1.8M | -1.57M | -1.03M | 2.15M | 5.16M | 6.11M | 4.56M | 1.2M | n/a | -2.24M | -1.41M | -1.24M |
Shares Outstanding (Basic) | 228.36M | 226.05M | 200.19M | 188.84M | 188.81M | 182.91M | 172.66M | 174.87M | 170.59M | 170.13M | 170.01M | 169.79M | 169.07M | 169.65M | 167.62M | 167.62M | 159.6M | 158.72M |
Shares Outstanding (Diluted) | 228.36M | 226.05M | 200.19M | 188.84M | 188.81M | 182.91M | 172.66M | 174.87M | 170.59M | 170.13M | 170.01M | 169.79M | 169.73M | 169.65M | 167.62M | 167.62M | 162.91M | 158.72M |
EPS (Basic) | -0.18 | -0.08 | -0.1 | -0.11 | -0.13 | -0.13 | -0.12 | -0.14 | -0.13 | -0.16 | -0.18 | -0.31 | -0.32 | -0.3 | -0.26 | -0.07 | -0.08 | -0.09 |
EPS (Diluted) | -0.18 | -0.08 | -0.1 | -0.11 | -0.13 | -0.13 | -0.12 | -0.14 | -0.13 | -0.16 | -0.18 | -0.31 | -0.32 | -0.29 | -0.25 | -0.07 | -0.08 | -0.09 |
EBITDA | -34.94M | -20.89M | -20.87M | -22.1M | -24.93M | -24.06M | -24.04M | -24.32M | -22.85M | -22.05M | -21.79M | -43.15M | -44.74M | -47.57M | -48.11M | -25.84M | -25.47M | -24.44M |
EBIT | -15.46M | -21.32M | -21.48M | -22.73M | -25.59M | -24.75M | -24.73M | -25.01M | -23.56M | -22.77M | -22.52M | -44.12M | -45.71M | -48.56M | -49.21M | -26.86M | -26.74M | -26.06M |
Depreciation & Amortization | 456K | 598K | 609K | 633K | 668K | 696K | 692K | 705K | 707K | 715K | 722K | 720K | 741K | 771K | 889K | 1.04M | 1.29M | 1.63M |